Updated Vectibix prescribing information - MPR
Links shared publicly online about this topic.
- 1,884total visits
Updated Vectibix prescribing information - MPR
empr.com —
View full resource at empr.com
Tags: Colorectal Cancer Medication, FDA, Vectibix
Most Recently Shared on July 20, 2009 at 4:11 pm By:
MPR News: Updated Vectibix prescribing information: The FDA has approved revisions to the prescribing i.. http://bit.ly/TMBRH
MIMS Online | Facebook
facebook.com — “MIMS Online - Welcome to the MIMS page! Get regular prescribing updates and other interesting MIMS-related information here - General Information: MIMS publications are independently compiled by our editorial team and are widely used by healthcare professionals in particular general practitioners, pharmacists and nurse prescribers. - Description: MIMS, or the Monthly Index of Medical Specialities, has been providing healthcare professionals with information on prescription medicines every... | F” View full resource at facebook.com
Most Recently Shared on March 2, 2012 at 2:35 pm By:
We’ve made some interesting changes to our Facebook page. Take a look at http://t.co/Wba2LYGE (preferably after you’ve finished lunch…)
PharmaLive: Seattle Genetics Announces Updates to Adcetris Prescribing Information
pharmalive.com — “PharmaLive: Seattle Genetics Announces Updates to Adcetris Prescribing Information” View full resource at pharmalive.com
Most Recently Shared on January 13, 2012 at 6:00 pm By:
Seattle Genetics Announces Updates to Adcetris Prescribing Information: http://t.co/mTYQjFW4
Cushing's Help and Support
cushie.info — “Welcome to Cushing's Help and Support. This site provides information, support, RSS feeds, news, and education for people with Cushing's or other endocrine problems, their friends and families. Cushing's syndrome is a hormonal disorder caused by prolonged exposure of the body's tissues to high levels of cortisol. This website also deals with Thyroid Disorders, Addison's Disease, Adrenal Disorders, Cushing's Syndrome, Pituitary Disorders, Pituitary disease, Growth Hormone, Pheochromacytomas, Fibr” View full resource at cushie.info
Most Recently Shared on November 10, 2011 at 6:30 pm By:
Diabetes in Cushing syndrome: basic and clinical aspects http://t.co/5fWcLPil #cushings
HealthSavers : Miraculous Magnesium
healthsavers.info — “Constantly updated research information on therapeutic nutritionals for congestive heart failure and all forms of cardiovascular disease - protocols for replacing routinely prescribed deadly drug regimens with research supported, pharmaceutical grade, physician recommended supplements.” View full resource at healthsavers.info
Most Recently Shared on September 6, 2011 at 11:28 pm By:
News in Brief: Week of Aug. 22-26 -- AAFP News Now -- American Academy of Family Physicians
aafp.org — “This roundup includes the following news briefs: AstraZeneca Updates Prescribing Information for Asthma Drug; Report Shows More Children Covered by Medicare, CHIP; CMS Takes Steps to Expand Competitive Bidding Program; and Graham Center’s UDS Mapper Takes First Place at International Conference.” View full resource at aafp.org
Most Recently Shared on August 24, 2011 at 11:26 pm By:
Janssen Products, LP Modifies Prescribing Information for PROCRIT (Epoetin alfa) in Chronic Kidney Disease - Drugs.com MedNews
drugs.com — “Revised prescribing information reflects FDA guidance to update labeling for all drugs within ESA class HORSHAM, Pa., Janssen Products, LP, formerly Centocor Or” View full resource at drugs.com
Most Recently Shared on June 24, 2011 at 9:06 pm By:
Janssen Products, LP Modifies Prescribing Information for PROCRIT (Epoetin alfa) in Chronic Kidney Disease... http://bit.ly/m5idvC #drug
U.S. Prescribing Information for Simvastatin Revised to Include New Limits on the Use of the Highest Dose -- 80 mg -- and Updated Drug Interaction Information - Drugs.com MedNews
drugs.com — “Jun 8, 2011 - Merck (NYSE MRK), known as MSD outside the United States and Canada, today announced changes to the prescribing information in the United States f” View full resource at drugs.com
Most Recently Shared on June 8, 2011 at 8:08 pm By:
U.S. Prescribing Information for Simvastatin Revised to Include New Limits on the Use of the Highest Dose ... http://bit.ly/k3UOuv #drug
FDA Drug Safety Communication: Updated Risk Evaluation and Mitigation Strategy (REMS) to Restrict Access to Rosiglitazone-containing Medicines including Avandia, Avandamet, and Avandaryl
fda.gov — “The U.S. Food and Drug Administration (FDA) is informing the public of new restrictions to the prescribing and use of rosiglitazone-containing medicines.” View full resource at fda.gov
Most Recently Shared on May 18, 2011 at 6:06 pm By:
Updated Risk Evaluation & Mitigation Strategy to Restrict Access to Rosiglitazone-containing Medicines (FDA) http://1.usa.gov/lwECEi
Up-to-date e-Rx guide includes new rules, incentives - ARRA News
mhanewsnow.typepad.com — “Guidelines for providers moving to e-prescribing have been updated to include rule changes and information on incentives. The American Medical Association, American Academy of Family Physicians, American College of Physicians, Medical Group Management Association, eHealth Initiative and Center for Improving Medication Management collaborated on the guide. Read more here.” View full resource at mhanewsnow.typepad.com
Most Recently Shared on April 29, 2011 at 4:12 pm By:
Up-to-date e-Rx guide includes new rules, incentives http://bit.ly/jjo7w3
AmericanEHR Partners
blog.americanehr.com — “From a press release published April 26, 2011: Five partner organizations today issued an updated 2011 edition of A Clinician--™s Guide to Electronic Prescribing. This --how-to-- guide helps health care professionals make informed decisions about how and when to transition from paper to e-prescribing systems. First created in 2008, the...” View full resource at blog.americanehr.com
Most Recently Shared on April 27, 2011 at 10:16 pm By:
AmericanEHR Partners Updated Guide to E-Prescribing http://goo.gl/ZzWlW Excellent, free 56 pg pdf by AAFP, ACP, MGMA et al
February 2011
fda.gov — “Monthly Safety Labeling Changes includes 53 products with revisions to drug Prescribing Information.” View full resource at fda.gov
Most Recently Shared on March 15, 2011 at 10:48 pm By:
FDA Safety Information updates > February 2011 http://t.co/6Vqyz2m via @AddThis #pharm #nurse #PCP
RheumWATCH
rheumatology.org — “These issue updates are sent by fax/e-mail to Advocates and ACR leadership on the 15th of each month, keeping them informed about the ACR's efforts in Washington.” View full resource at rheumatology.org
Most Recently Shared on January 31, 2011 at 1:40 pm By:
Check out this month's RheumWATCH featuring info on physician payment rates for 2011, retroactive DXA payments & more: http://ow.ly/3MARf
FDA: Aseptic Meningitis Risk With Use Of Seizure Drug Lamictal - QualityPoint Technologies
qualitypointtech.net — “The U.S. Food and Drug Administration warned that the drug Lamictal (lamotrigine), approved to treat seizures and bipolar disorder, can cause aseptic meningitis, an inflammation of the protective membranes (meninges) that cover the brain and spinal cord not caused by bacterial infection. The agency is working with the drug's manufacturer, GlaxoSmithKline, to update the prescribing information and patient medication guide to include this risk...” View full resource at qualitypointtech.net
Most Recently Shared on August 16, 2010 at 2:27 pm By:
FDA: Aseptic Meningitis Risk With Use Of Seizure Drug Lamictal: The U.S. Food and Drug Administration warned that ... http://bit.ly/9WJ4v9
Lamictal can cause aseptic meningitis: FDA
news-medical.net — “The U.S. Food and Drug Administration today warned that the drug Lamictal (lamotrigine), approved to treat seizures and bipolar disorder, can cause aseptic meningitis, an inflammation of the protective membranes (meninges) that cover the brain and spinal cord not caused by bacterial infection.The agency is working with the drug's manufacturer, GlaxoSmithKline, to update the prescribing information and patient medication guide to include this risk.” View full resource at news-medical.net
Most Recently Shared on August 13, 2010 at 4:51 pm By:
Meningitis News: Lamictal can cause aseptic meningitis: FDA: The U.S. Food and Drug Administration today warned th... http://bit.ly/bNWNDT
FDA warns Lamictal can cause aseptic meningitis
news-medical.net — “The U.S. Food and Drug Administration today warned that the drug Lamictal (lamotrigine), approved to treat seizures and bipolar disorder, can cause aseptic meningitis, an inflammation of the protective membranes (meninges) that cover the brain and spinal cord not caused by bacterial infection.The agency is working with the drug's manufacturer, GlaxoSmithKline, to update the prescribing information and patient medication guide to include this risk.” View full resource at news-medical.net
Most Recently Shared on August 13, 2010 at 8:34 am By:
FDA warns Lamictal can cause aseptic meningitis: The U.S. Food and Drug Administration today warned that the drug ... http://bit.ly/9JTYuF
Advertisement

